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Synopsis  
 
EmbR is a transcriptional regulator which is phosphorylated by the cognate mycobacterial 
serine/threonine protein kinase PknH. Recent studies demonstrated that PknH-dependent 
phosphorylation of EmbR enhances its DNA-binding activity and activates transcription of the 
embCAB genes encoding arabinosyltransferases which participate in arabinan biosynthesis. 
Herein, we identified a genomic region of 4425-bp, that is present in Mycobacterium 
tuberculosis CDC1551, but absent from M. tuberculosis H37Rv, comprising the MT3428 gene, 
which is homologous to embR. Homology modelling of the MT3428 gene product illustrated its 
close relationship (56% identity) to EmbR, and was hence termed EmbR2. In marked contrast to 
EmbR, EmbR2 was not phosphorylated by PknH, although it is a substrate of other M. 
tuberculosis kinases, including PknE and PknF. Tryptophan fluorescence emission of EmbR2 
was monitored in the presence of three different PknH-derived phosphopeptides and 
demonstrated that EmbR2 binds to at least two of the threonine sites known to undergo 
autophosphorylation in PknH. We observed that the capacity of EmbR2 to physically interact 
with PknH without being phosphorylated was a result of EmbR2-mediated inhibition of kinase 
activity: incubation of PknH with increasing concentrations of EmbR2 led to a dose-response 
inhibition of the autokinase activity, similarly to O6-cyclohexylmethylguanine, a known 
inhibitor of eukaryotic cyclin-dependent kinases. Moreover, EmbR2 inhibited PknH-dependent 
phosphorylation of EmbR in a dose-dependent manner. Together, these results suggest that 
EmbR2 is a regulator of PknH activation, thus directly participating in the control of the 
PknH/EmbR pair and potentially in mycobacterial physiology/virulence of M. tuberculosis 
CDC1551.  
 
 
 
Keywords: Mycobacterium, phosphorylation, Ser/Thr protein kinase, PknH, EmbR, EmbR2, 
inhibitor, FHA domain, structural model 
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Introduction 
 
Genes encoding functional Serine/Threonine Protein Kinases (STPKs) are ubiquitous in 
prokaryotic genomes, but little is known regarding their physiological substrates and their 
participation in bacterial signal transduction pathways and their regulation. Based on their 
genomic context, many of the 11 STPKs from Mycobacterium tuberculosis (M. tb) were 
proposed to participate in regulation of diverse physiological functions [1]. An increasing body 
of evidence indicates that the STPKs play important roles in the physiology and virulence of M. 
tb and are potential therapeutic targets for future drug development against tuberculosis [2]. 
Recent studies have provided evidence that at least two kinases, PknG and PknH, play a role in 
the virulence of M. tb [3-5]. PknG contributes to the survival of mycobacteria within 
macrophages by preventing fusion of phagosomes with lysosomes [5]. In contrast, it was 
demonstrated that a PknH mutant of M. tb is hypervirulent in infected mice and it was proposed 
that PknH regulates intracellular bacterial growth particularly during the chronic phase [4].  
Since EmbR (Rv1267c) and the sensor-like Ser/Thr kinase PknH (Rv1268c) are adjacent 
in the M. tuberculosis genome, we first investigated whether EmbR may represent an 
endogenous substrate of PknH. We found that EmbR was phosphorylated by PknH in vitro, and 
that the interaction with the kinase was mediated by EmbR's C-terminal FHA (ForkHead 
Associated) domain [6]. FHA domains are small protein modules capable of mediating protein-
protein interactions through pThr recognition, and often participate in protein-protein 
interactions in STPK-dependent signal transduction pathways [7]. Truncation of the EmbR FHA 
domain or point mutations altering conserved residues in the phosphothreonine-binding pocket 
dramatically diminished PknH-mediated threonine phosphorylation of EmbR [6]. Elucidation of 
the three-dimensional structure of EmbR revealed that, in addition to the FHA domain, it 
possesses two major domains, an N-terminal winged helix-turn-helix DNA-binding domain 
followed by a central bacterial transcription activation (BTA) domain, suggesting that EmbR 
may act as a transcriptional regulator in M. tb [8]. This was recently supported by the fact that 
phosphorylation of EmbR enhances its DNA binding activity towards promoter regions of 
embCAB genes [9]. The corresponding gene products are known to participate in the 
biosynthesis of arabinogalactan and lipoarabinomannan which are critical components of the 
mycobacterial cell wall [10-12]. The PknH-mediated increase in the transcription of embAB also 
alters resistance to ethambutol, a frontline antituberculosis drug known to target embAB [10, 11]. 
These results along with the in vivo up-regulation of PknH inside host macrophages [13] suggest St
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a functionally relevant signalling mechanism involving the PknH-EmbR-EmbCAB. In addition, 
Sharma et al. demonstrated that the Ser/Thr protein kinases PknA and PknB also regulate the 
signalling pathway leading to EmbR phosphorylation [9]. 
In a related actinomycete, Corynebacterium glutamicum, phosphoproteome studies 
experimentally determined 120 unique Ser/Thr-phosphorylated proteins that are phosphorylated 
by only four STPKs [14]. In support of these results, using a bioinformatic approach, 40 
potential PknH substrates were identified (including EmbR) in M. tb, and two of the newly 
predicted substrates were experimentally shown to be phosphorylated by PknH in vitro [15]. 
These two substrates, which lack an FHA domain, are Rv0681, a TetR-class transcription factor, 
and DacB1, a penicillin-binding protein [15]. The presence of a large number of FHA and non-
FHA-containing substrates of PknH in M. tb suggests a possible participation of this kinase in 
numerous signalling pathways. Since PknH appears as a key determinant of pathogen virulence 
[4], it is very likely that further characterization of the various endogenous substrates and 
regulatory mechanisms will increase our understanding of the physiology and pathogenicity of 
M. tb. One possible mechanism of regulating the phosphosignalling responses is to control the 
rate of phosphorylation of both the kinases and the substrates, which can be achieved in vitro and 
in vivo by Ser/Thr phosphatases. To date, only one Ser/Thr-phosphatase, termed PstP, has been 
found in the M. tb genome mediating dephosphorylation of kinases [16] as well as substrates 
[17]. However, it is unlikely that PstP represents the only factor that controls the phosphorylation 
status of all eleven STPKs and all substrates in vivo. We reasoned that additional mechanisms of 
controlling/regulating the phosphorylation status of PknH may exist. In Streptomyces coelicolor 
A3(2), the KbpA protein which is involved in actinorhodin production has been demonstrated to 
bind to the STPK AfsK and to inhibit its autophosphorylation activity at serine and threonine 
residues [18]. KbpA also inhibited phosphorylation of AfsR, which is the substrate of AfsK, 
presumably because KbpA inhibited the conversion from the inactive nonphosphorylated form 
of AfsK to the active phosphorylated form [18].  
In light of this study, we extended our previous work on the characterization of the 
PknH/EmbR pair by identifying and characterizing a protein from M. tuberculosis CDC1551 that 
interferes specifically with the autokinase activity of PknH, subsequently inhibiting PknH-
dependent phosphorylation of EmbR. This protein, termed EmbR2, closely related to EmbR, is 
capable of interacting with PknH, but cannot be phosphorylated by this kinase. We predict that 
this protein would represent a bait for PknH and may represent a novel mechanism of regulation 
of the PknH/EmbR couple.  
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Materials and Methods  
 
Bacterial strains, plasmids, and growth conditions 
Overproduction of EmbR2 was performed in Escherichia coli strain C41(DE3) [19]. E. coli 
TOP-10 (Invitrogen) was used to propagate plasmids in cloning experiments. All strains were 
grown and maintained at 37 °C in LB medium supplemented with either 25 µg/ml kanamycin or 
100 µg/ml ampicillin, when required. Plasmids pET28a and pCR-BluntII-TOPO were purchased 
from Novagen and Invitrogen, respectively. 
 
Expression and purification of GST-tagged Ser/Thr protein kinases from M. tuberculosis  
Plasmids designed to express the eight catalytic domains of Ser/Thr protein kinases (PknA, 
PknB, PknD, PknE, PknF, PknH, PknK, and PknL) fused to glutathione-S-transferase (GST) 
were constructed by PCR amplification using M. tuberculosis H37Rv genomic DNA as a 
template as described previously [17]. Kinases were purified using  glutathione-Sepharose 4B 
matrix as reported earlier [17]. 
 
Expression and purification of a His6-tagged EmbR and EmbR2 
Construction of pET28a-embR expression vector was used to overproduce EmbR in C41(DE3) 
E. coli cells as reported earlier [6]. The embR2 gene (MT3428), with appropriate sites at both 
ends, was synthesized by PCR amplification using M. tuberculosis CDC1551 genomic DNA as a 
template and the following primers: embR2-up 5’-CC CAT ATG GCC CGA AAC GAA CTC 
CG-3' (NdeI site underlined) and embR2-lo 5'-GGA TCC TAA CGG CCC GAT TCG TG-3' 
(BamHI underlined). This 1156-bp DNA fragment was directly ligated into the pCR-BluntII-
TOPO, yielding the pCRII-BluntII-embR2 construct. The embR2 insert was then extracted and 
purified following restriction of pCRII-BluntII-embR2 with NdeI and BamHI, and subsequently 
ligated into the NdeI/BamHI-restricted pET28a, thus giving rise to pET28a-embR2, which was 
used to transform E. coli C41(DE3) cells. Cultures were incubated at 37 °C under shaking until 
A600 reached 0.5. IPTG was then added at a final concentration of 1 mM, and growth was 
continued for an additional 3 h at 30 °C. Cells were harvested by centrifugation at 6,000×g for 
10 min, washed in 10 ml of buffer A (50 mM Tris/HCl pH7.5; 150 mM NaCl; 10% glycerol; 1 
mM β-mercaptoethanol; 1 mM EDTA; 10 mM imidazole) containing DNAse, RNAse and a 
protease inhibitor cocktail (Roche). Bacteria were then disrupted in a French pressure cell and 
the resulting extract was centrifuged for 30 min at 27,000 × g at 4°C. The supernatant was St
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collected and incubated for 2 hours at 4°C on a rotating wheel with Ni-NTA agarose (Qiagen) 
previously equilibrated with buffer A. After extensive washing with buffer A, bound proteins 
were eluted with elution buffer (50 mM Tris/HCl pH7.5; 150 mM NaCl; 10% glycerol; 1 mM β-
mercaptoethanol; 1 mM EDTA; 300 mM imidazole). Pure EmbR2 fractions were pooled, 
dialyzed against 50 mM Tris/HCl pH7.5, 150 mM NaCl, 10% glycerol, 1 mM β-
mercaptoethanol, 1 mM EDTA to remove imidazole and stored at –20°C until further use.  
 
Site-directed mutagenesis 
Site-directed mutagenesis was carried out based on PCR amplification. A first set of PCR 
amplifications was generated using pET28a-embR2 as a template along with the primer pair, 
#428 (5'-GCC CTG TGG ACG CAA CTC ATC ACC GCA TAC TAT-3') and # 431 (5’- TAT 
GGA TCC CTA ACG GCC CGA TTC GTG CGG -3') to generate embR2-R204T/A208T. This 
PCR product was then used as a primer in a second round of PCR amplification in combination 
with primer #430 (5’- TAA TAG CT CAT ATG GCC CGA AAC GAA CTC CGG TTC-3') to 
generate the entire 1146-bp embR2 gene. This DNA fragment, containing the appropriate sites at 
both ends, was restricted by NdeI and BamHI (sites italicized) and ligated in the NdeI/BamHI-
restricted pET28a, generating pET28a-embR2-R204T/A208T. The nucleotide changes in the 
different primers to allow specific amino acid replacement are underlined. Mutations were 
verified by DNA sequencing. The His-tagged EmbR2 mutant protein was overexpressed and 
purified as described above. 
 
In vitro kinase assay 
In vitro phosphorylation of about 1 µg (15 pmol) of each STPK was carried out for 15 min at 
37°C in a reaction mixture (20 µl) containing buffer P (25 mM Tris-HCl, pH 7.0; 1 mM DTT; 5 
mM MgCl2; 1 mM EDTA) with 200 µCi/ml [γ-33P]ATP. Phosphorylation of EmbR or EmbR2 
was performed with 3 µg (66 pmol) of EmbR or EmbR2 in 20 µl of buffer P with 200 µCi/ml [µ-
33P]ATP and 250 ng of kinase for 15 min at 37°C. In vitro inhibition assays were carried out 
with 0.5 to 3 µg of EmbR2 (0.55 µM to 3.3 µM) or with 5 to 100 µM of O6-
cyclohexylmethylguanine. The reaction was stopped by addition of an equal volume of 2X 
sample buffer and the mixture was heated at 100°C for 5 min. After electrophoresis, gels were 
soaked in 16% TCA for 10 min at 90°C, dried and exposed to films. Intensity of the radioactivity 
was measured with a Molecular Dynamics Typhoon phosphoimager. 
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Phosphopeptide binding assay 
Intrinsic Trp-fluorescence emission was measured between 300 and 400 nm (scan speed 100 
nm/min), using a Perkin Elmer Luminescence Spectrometer LS 50B, exciting the sample at a 
wavelength of 295 nm. Spectra were recorded for each peptide aliquot (1 µl) added to 400 µl of a 
5 µM solution of EmbR2, until reaching a final peptide concentration of 0.5 mM (11 additions). 
A plot of fluorescence intensity at 330 nm vs. peptide concentration (3 independent experiments) 
resulted in a binding isotherm that was fitted to a one-site saturation model (SigmaPlot, Systat 
Software Inc.). 
 
Analysis of the phosphoamino acid content of proteins  
Phosphoamino acid analysis of the EmbR or EmbR2 proteins labelled in vitro with either PknE, 
PknF or PknH was performed as previously described [20]. 
 
Homology model of EmbR2 
A homology model of the molecular structure of Mt-CDC1551 EmbR2 was derived based on the 
crystal structure of EmbR bound to the phosphopeptide SLEVpTEADT [8]. Models were 
obtained from several web-based modelling servers, including Swiss-Model [21], Geno3D [22], 
and 3D-JIGSAW [23]. The homology models were analyzed in comparison to the chain A 
complex of the phosphopeptide-bound structure of EmbR (pdb entry 2FF4, [8]).   
 
Synthesis of O6-cyclohexylmethylguanine 
The target sample was prepared by the method of Arris et al. [24]. CHCl3:MeOH (20:1) was 
used for purification via silica gel column chromatography yielding a single spot on thin layer 
chromatography: white solid, yield 66%, mp 202-204 oC (dec.). 1H NMR (300 MHz, Me2SO-d6) 
d 12.38 ppm (bs, 1H, NH), 7.79 (s, 1H, H-8), 6.21 (bs, 2H, NH2), 4.20 (d, 2H, -OCH2-, J = 
6.1Hz), 182-162 (m, 6H, cyclohexyl H’s), 1.32-0.97 (m, 5H, cyclohexyl H’s). FABMS m/z: 248 
(M+H)+.  HRMS (ESI) calcd for (M+H)+ (C12H17N5O) 248.15059, found 248.15083.  
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Results and Discussion 
 
Identification of EmbR2 in M. tuberculosis CDC1551  
In this study, we extended our previous studies by deciphering a new mechanism of regulation of 
phosphorylation of EmbR by PknH. To this end, we first explored the genome of M. tb strain 
CDC1551 which, in contrast to the laboratory strain M. tb H37Rv, is involved in a recent cluster 
of tuberculosis cases and is known to be transmissible and virulent in humans [25]. The 
CDC1551 strain appears to be highly infectious in humans, is comparable in virulence to strain 
H37Rv in animal models [26], and has greater immunoreactivity than H37Rv and other clinical 
strains due to increased induction of TNF-α, IL-6, IL-10, and IL-12 [27]. We identified a 
genomic region of 4425-bp that is present in CDC1551, but absent from M. tb strain H37Rv, 
comprising the MT3428 gene [28] (Figure 1A). The insertion sequence IS6110 is the principal 
epidemiological marker for M. tb. A number of the insertions and deletions were associated with 
this insertion sequence, suggesting a role for this element in genome plasticity [29]. The 
presence in H37Rv of IS6110 lacking the 3- to 4-bp direct repeat directly adjacent to the deleted 
region relative to strain CDC1551 indicates that this deletion was associated with a possible 
mechanism of homologous recombination between nearby IS6110 elements [30]. We also found 
the MT3428 gene in other mycobacterial species, including M. bovis and M. bovis BCG (data not 
shown). MT3428, annotated as a putative transcriptional regulator, is highly homologous to 
EmbR. Indeed, the amino acid sequences of M. tb H37Rv EmbR and M. tb CDC1551 MT3428 
(termed EmbR2) align with 55% sequence identity over 381 residues (alignment using ClustalW, 
Figure 1B). The alignment is almost free from insertions and deletions. A single-residue gap in 
the FHA domain of EmbR2 maps to residue 300 (EmbR), while an N-terminal 5-residue deletion 
is located within the first eight residues in the sequence. In contrast to embR, which is genetically 
linked to pknH [6, 31], embR2 is found to be genetically distant from pknH.  
We have generated homology models of EmbR2 based on our recently determined high 
resolution X-ray crystal structure of EmbR [8]. This seemed justified based on the high level of 
sequence identity and the very good resolution of the template structures (PDB: 2FEZ 2.0 Å, 
2FF4 1.9 Å). Algorithm-specific bias of the modeling outcome was minimized by generating 
models using a range of modeling servers. As expected, all models display a conserved backbone 
conformation for the N-terminal DNA-binding, the central BTA and the C-terminal FHA domain 
(Figure 1C). The models only diverge slightly around residue 294, where the FHA domain of 
EmbR2 lacks a residue relative to EmbR. This model clearly confirms the characterization of St
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EmbR2 as a structural homologue of EmbR. We, thus, addressed the question whether cross-
regulation/interaction between these two proteins with PknH would occur.  
 
EmbR2 is not phosphorylated by PknH 
We first investigated whether EmbR2 represents a substrate of PknH. To this end, PknH was 
expressed as a GST fusion [6], whereas EmbR and EmbR2 were expressed and purified as His-
tag fusions. When incubated with purified EmbR in the presence of [γ-33P]ATP, PknH was able 
to phosphorylate EmbR, consistent with our previous results (Figure 2) [6]. In stark contrast, 
EmbR2 was not phosphorylated by PknH in vitro (Figure 2). This was rather unexpected given 
the high degree of sequence and structural conservation between these two proteins, an identical 
domain organisation and invariance of three key residues in the FHA domain (Arg312, Ser326 
and Asn348) that are required for recognition of EmbR by PknH [6].  
In their attempt to identify endogenous substrates of the PknH kinase, Zheng et al. 
searched the M. tb genome database for open reading frames containing sequences similar to the 
motif TQLGT which encompasses a site of autophosphorylation in the activation loop of PknH, 
reasoning that the autophosphorylation and kinase activity may target similar amino acid motifs 
[15]. This allowed the identification of 40 putative substrates, including EmbR (containing a 
TQLIT motif), Rv0681 (containing a TQLGT motif) and DacB1 (containing a TQIGT motif). 
Substitution of the first Thr residue in this motif by an Ala residue completely abolished Rv0681 
phosphorylation by PknH, whereas in the case of EmbR and DacB1 phosphorylation by PknH 
was significantly reduced compared to the wild-type proteins [15]. EmbR2 contains a RQLIA 
motif instead of the TQLIT motif present in EmbR (Figure 1B). To investigate the possibility 
that absence of phosphorylation of EmbR2 by PknH correlates with the lack of the TQLIT motif, 
both the Arg204 and Ala208 were simultaneously replaced by two Thr residues to restore a 
genuine TQLIT motif within EmbR2. However, when tested in the presence of [γ-33P]ATP, 
PknH still failed to phosphorylate the EmbR2-R204T/A208T mutant (Figure 2). This indicates 
that the lack of a TQLGT motif in EmbR2 is not responsible for the absence of phosphorylation 
by PknH.  
 
STPK-mediated phosphorylation of EmbR and EmbR2 
Overlapping substrate specificity of different M. tb kinases has been reported earlier [17, 32, 33]. 
This prompted us to investigate whether EmbR2 could be phosphorylated by other M. tb STPKs. 
EmbR2 was found to be phosphorylated by PknE and PknF (Figure 3A). Whereas PknF 
phoshorylates EmbR and EmbR2 equally well, PknE preferentially phosphorylates EmbR over 
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EmbR2. In marked contrast, PknH is unable to phosphorylate EmbR2, but phosphorylates 
EmbR, similarly to PknE/F. This suggests different levels of substrate specificity of the different 
STPKs. A corollary, arising from these experiments is that EmbR and EmbR2, as they interact 
with multiple STPKs, may be regulated by multiple signals. Although a complex network of 
interactions between EmbR/EmbR2 and the different STPKs may exist, it remains to be 
established whether this STPK cross-talk occurs in vivo.  
We next analysed the nature of the phosphorylated amino acid residues in EmbR/EmbR2 
after in vitro phosphorylation with PknE, PknF or PknH. Following incubation with the kinases 
and [γ-33P]ATP, labeled proteins were separated by SDS-PAGE, excised, and subjected to acid 
hydrolysis. Figure 3B shows that, in agreement with our previous results [6], EmbR was 
phosphorylated by PknH only on threonine residues. However, analysis of the phosphoamino 
acid content of PknE-phosphorylated EmbR revealed that phosphorylation occurs on both 
threonine and serine residues, whereas PknF phosphorylated EmbR only on serine residues. 
These unexpected results prompted us to explore the phosphoamino content of the different 
Pkn/EmbR2 couples. Whereas EmbR2 was preferentially phosphorylated at threonine residues in 
the presence of PknE (with minor amounts of phosphoserine being detected), it was mainly 
phosphorylated  at serine residues in the presence of PknF. As for EmbR, these results show that 
the nature of the phosphorylation sites is kinase-dependent. Furthermore, comparison of the 
phosphoamino profiles of EmbR and EmbR2 in relation with the different kinases also revealed  
that the nature of the phosphorylation sites is also dependent of the substrate. PknF 
phosphorylates EmbR strictly at serines, whereas PknF phosphorylates EmbR2 at both serines 
and threonines. 
 
Physical interaction between EmbR2 and PknH-derived phosphopeptides 
PknH was shown to possess autokinase activity on nine Ser and Thr residues [6, 34] and one of 
the Thr sites located within the kinase activation loop, Thr170, is required for PknH-mediated 
phosphorylation of EmbR [6]. As EmbR2 contains three Trp residues, we assessed ligand-
binding by intrinsic Trp fluorescence. Intensity of Trp fluorescence emission at 330 nm was 
monitored as a function of concentration of three different PknH-derived phosphopeptides 
(DEKLpTQLGT containing the pThr170, TQLGpTAVGT containing the pThr174, 
DSAGpTLVSS containing the pThr222) as well as using a non-specific phosphopeptide derived 
from the high-affinity ligand of the FHA domain of the yeast Rad53p check-point kinase [7] 
(SLEVpTEADT). Changes of the emission intensity at 330 nm with increasing peptide 
concentrations reflect ligand binding, and the equilibrium dissociation constant Kd can be St
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derived by fitting the resulting binding isotherm (Table 1). Each of the phosphopeptides bound 
with an equilibrium dissociation constant (Kd) in the order of 15 µM. This is in marked contrast 
to binding data obtained with EmbR, where only the Rad53p-derived peptide caused a 
measurable change in the emission signal, indicating a Kd of about 175 µM [8]. Therefore, these 
results suggest that EmbR2 binds to at least two of the threonine sites known to undergo 
autophosphorylation in PknH [34].  
Overall, the absence of PknH-mediated phosphorylation of EmbR2 despite low-µM 
interaction of the latter with at least three likely docking sites on the kinase, lead us to 
hypothesise that EmbR2 may not act as a substrate of PknH but rather as an inhibitor. 
 
Selective inhibitory effect O6-cyclohexylmethylguanine towards M. tb kinases 
Cyclin-dependent kinases are increasingly recognized as important targets for therapeutic 
intervention in various proliferative disease states, including cancer [35]. O6-
cyclohexylmethylguanine has been reported as a newly discovered ATP-competitive purine-
based inhibitor of CDK1/cyclin B1 and CDK2/cyclin A3, the O6 substituent occupying the 
kinase ribose binding sites [24, 36]. Notably, screening of a small library of approximately 5,000 
compounds from Southern Research through the Tuberculosis Antimicrobial Acquisition and 
Coordinating Facility (www.taacf.org) identified a small number of 6-alkylthio- and O6-alkyl-
purines as well as 2,4-disubstituted- and 2,4,6-trisubstituted pyrimidines that were relatively 
active versus M. tb H37Rv in vitro [37]. A cheminformatic search of the scaffolds suggested that 
these simple analogs may be ATP-competitive inhibitors of signaling kinases in M. tb. Recent 
publications support that these purine and pyrimidine scaffolds show broad and excellent 
antitubercular activity [38-40], and, in certain cases, antibacterial and enzymatic activity versus 
ATP-requiring bacterial kinases. Preliminary screening of several active samples from the 
TAACF in vitro screen identified the reported ATP-competitive CDK inhibitor O6-
cyclohexylmethylguanine as a potential inhibitor of PknH (data not shown). Thus, we tested the 
capacity of O6-cyclohexylmethylguanine (Figure 4A) to interfere with the autokinase activity of 
eight M. tb STPKs in vitro. The catalytic domains of the kinases were purified as GST-fusion 
proteins [17] and incubated individually with [γ-33P]ATP in the absence or presence of 50 µM 
O6-cyclohexylmethylguanine. Figure 4A shows that this compound selectively inhibited the 
various kinases. Whereas the drug did not appreciably alter the activity of PknA, PknB, PknF, 
PknK or PknL, it exhibited a potent inhibitory effect on PknH and PknE, and completely 
abrogated autophosphorylation activity of PknD. Comparative sequence analysis allowed St
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grouping of the eleven M. tb kinases into three distinct homology clusters (PknA/B/L, PknF/I/J 
and PknD/E/H), while the two soluble enzymes (PknG and PknK) stand apart from all the others 
[2, 41]. Our results clearly indicate that O6-cyclohexylmethylguanine exhibits specific activity 
against the third group of kinases only, supporting the notion that PknD/E/H belong to the same 
clade. It also demonstrates the feasibility to design inhibitors that will target specifically one 
clade rather than another. This selectivity is of particular interest since signalling elements, 
including STPK, may represent a new class of attractive targets, and the expertise in designing 
such inhibitors for eukaryotic STPKs represent an intense research area [42] and could be 
exploited for the development of new antitubercular drugs. 
Figure 4B (left panels) shows that O6-cyclohexylmethylguanine inhibited PknH autokinase 
activity in a dose-dependent fashion, with an IC50 value of around 5 µM. This prompted us to 
examine whether EmbR2 alters the autophosphorylation activity of PknH by incubating the 
kinase with increasing concentrations of EmbR2 in the presence of [γ-33P]ATP. Figure 4B (right 
panels) demonstrated inhibition of the autokinase activity of PknH in a dose-responsive manner, 
similarly to O6-cyclohexylmethylguanine. The IC50 value of EmbR2 was around 1.1 µM (1 µg 
of EmbR2 in the conditions used), thus indicating that a 5-fold excess of EmbR2 at a molar level 
was sufficient to inhibit 50% of the kinase activity of PknH.  
 
EmbR2 inhibits PknH-dependent phosphorylation of EmbR 
It is known that activation of kinases often depends on regulatory processes involving 
phosphorylation/dephosphorylation through an autocatalytic mechanism. For instance, the 
activation loop is a major control element of an active/inactive conformational switch in 
numerous kinases [43], and the conformation of the activation loop often depends on the 
phosphorylation state [44]. Based on structural studies, it is thought that the activation loop 
controls both the accessibility to the catalytic site and the binding of the substrate. Combining 
on-target dephosphorylation/MALDI-TOF MS and LC-ESI/MS/MS has recently allowed the 
identification of nine phosphorylation sites in PknH [34] resulting from autophosphorylation, a 
prerequisite to its kinase activity. Since EmbR2 inhibits autophosphorylation of PknH, PknH-
dependent phosphorylation of EmbR could be dependent on the presence of EmbR2. Figure 5 
clearly shows a dose-dependent inhibition of EmbR phosphorylation with increasing 
concentrations of EmbR2. However, when EmbR2 was replaced by an unrelated protein, for 
instance GST, there was no inhibitory effect on EmbR phosphorylation, thus demonstrating that 
the inhibitory effect was specific to EmbR2. These results suggest that, in the reaction mixture St
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containing PknH and EmbR, EmbR2 inhibited the phosphorylation of EmbR by PknH, 
presumably because EmbR2 prevents the conversion from the inactive non-phosphorylated form 
of PknH to the active phosphorylated form. It is noteworthy that a similar mechanism of 
regulation has been reported in S. coelicolor A3(2), in which the KbpA protein binds to and 
inhibits autophosphorylation of AfsK as well as phosphorylation of AfsR, the substrate of AfsK 
[18]. 
 
 
Concluding remarks 
 
The cell wall of pathogenic mycobacteria undergoes continuous changes in the course of growth, 
intramacrophagic survival or during infection in response to environmental changes [45] and 
many of the environmental stimuli are communicated within mycobacteria by sensor kinases 
present on the mycobacterial membrane [1]. PknH is unique to pathogenic mycobacteria, which 
is induced on infection of macrophages with M. tb [13]. The embCAB operon encoding 
arabinosyltransferases was identified as the cellular target of EmbR in M. tb [9]. PknH-
dependent phosphorylation of EmbR enhances the DNA binding activity of EmbR towards 
promoter regions of embCAB genes. The consequent enhanced transcription of embC results in a 
higher ratio of lipoarabinomannan (LAM) to lipomannan (LM) [9], which are two major cell 
wall lipoglycans. These complex molecules are important determinants in the mycobacterial 
physiology and in the modulation of the host immune system during disease progression [46]. 
Furthermore, PknH expression modestly alters ethambutol resistance by virtue of its ability to 
increase the transcription of the embA and embB genes [9]. Together, this establishes that 
embCAB activation is controlled by EmbR phosphorylation and connects the LAM/LM ratio 
with the phosphorylation status of PknH. However, little is known with respect to the regulation 
processes controlling PknH activation. Although this could be achieved (at least partially) by 
phosphorylation/dephosphorylation via the action of the Ser/Thr phosphatase PstP [16, 17], this 
study also suggests that EmbR2 could be a key regulator of PknH activation. We propose that 
PknH and EmbR form a pair participating in arabinan metabolism that can also be controlled by 
EmbR2, providing a novel mechanism of regulating phosphorylation of EmbR via PknH. In 
summary, this study describes an additional level of regulation of mycobacterial STPKs, which 
may explain how a limited number of kinases participate in many complex signalling pathways. 
It has been proposed that the PknH-mediated signalling pathways contribute to the regulation of 
bacillary load during the infection process [4]. Upon infection in mice, the M. tb H37Rv ∆pknH St
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mutant survived to a higher load in the mouse organs, especially during the chronic stage of 
infection, indicating that PknH plays a role in regulating bacillary load to facilitate adaptation to 
the host environment during the infection process. In this context, in vivo expression of EmbR2 
in M. tb CDC1551 or in other pathogenic species such as M. bovis (which possesses an identical 
embR2 gene), could inhibit PknH activation, and consequently increase the virulence phenotype 
of these strains. Whether EmbR2 plays an in vivo inhibitory role in a negative feedback system 
in the PknH/EmbR regulatory pathway and contributes to survival and hypervirulence in 
pathogenic mycobacteria remains to be determined . 
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Figure legends 
Figure 1. (A) Organization of the region of insertion containing the embR2 locus in M. 
tuberculosis CDC1551 relative to strain H37Rv. The thick line represents the 4.4-kb insertion 
region. The coordinates of the insertion  region and those of the embR2 gene are indicated, 
according to [28]. Arrows represent the direction of transcription. The embR2 gene is shown in 
grey. (B) Sequence alignment of EmbR from the strain H37Rv and EmbR2 from the strain 
CDC1551. Identical residues are shown in black. Arrowheads indicate the position of the three 
highly conserved FHA residues (Arg312, Ser326 and Asn348 with regard to the EmbR 
sequence). (C) Superposition of the Cα trace of EmbR (Yellow, PDB: 2FF4) with those of 
the homology models of EmbR2 (cyan – SWISSMODEL, magenta – 3DJIGSAW, blue – 
GENO3D). Shown in gray sticks is the phosphopeptide bound to the FHA domain of EmbR. 
Inset: region of the 1-residue deletion  in the FHA domain, leading to discrepancies in backbone 
conformation of the different homology models. 
 
Figure 2. In vitro phosphorylation of EmbR and EmbR2 by PknH. His-tagged fusion 
proteins were purified from E. coli C41(DE3) carrying either pET28a-embR, pET28a-embR2 or 
pET28a-embR2(R204T/A208T). Purified GST-PknH was incubated with 3 µg of either purified 
His-tagged EmbR, EmbR2 or EmbR2-R204T/A208T in the presence of [γ-33P]ATP for 15 min at 
37°C. Samples were separated by SDS-PAGE and detected by Coomassie blue staining (upper 
panels) and then exposed overnight to a film and visualized by autoradiography (lower panels). 
Positions of PknH, EmbR and EmbR2 are indicated.  
 
Figure 3. In vitro phosphorylation of EmbR and EmbR2 by PknE and PknF. (A) Purified 
GST-PknE and GST-PknF were incubated with either His-tagged EmbR (left panels) or His-
tagged-EmbR2 (right panels) with [γ-33P]ATP. Samples were separated by SDS-PAGE and 
visualized following Coomassie blue staninig (upper panels) or autoradiography after exposure 
to a film (lower panels). (B) Phosphoamino acid content of the Pkn-phosphorylated 
EmbR/EmbR2. EmbR and EmbR2 were phosphorylated in vitro in presence of either GST-
PknE, GST-PknF or GST-PknH and [γ-33P]ATP, analyzed by SDS-PAGE, electroblotted onto an 
Immobilon PVDF membrane, excised and hydrolyzed in acid. The phosphoamino acids thus 
liberated were separated by electrophoresis in the first dimension (1D) and ascending 
chromatography in the second dimension (2D). After migration, radioactive molecules were St
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detected by autoradiography. Authentic phosphoserine (P-Ser), phosphothreonine (P-Thr), and 
phosphotyrosine (P-Tyr) were run in parallel as internal standard controls, and visualized by 
ninhydrin staining. 
 
Figure 4. Dose-response inhibition of PknH autokinase activity by O6-
cyclohexylmethylguanine or EmbR2. (A) O6-cyclohexylmethylguanine inhibits PknD, PknE 
and PknH activity. Autophosphorylation inhibition by O6-cyclohexylmethylguanine was 
evaluated against eight out of the eleven M. tuberculosis STPKs by incubating the kinases with 
[γ-33P]ATP for 20 min at 37°C in the absence (-) or presence (+) of 50 µM of inhibitor. Samples 
were separated by SDS-PAGE and visualized by autoradiography. (B) Purified GST-PknH (0.3 
µg) were incubated with increasing concentrations of either  O6-cyclohexylmethylguanine (up to 
100 µM) or EmbR2 (up to 3 µg) in the presence of [γ-33P]ATP for 20 min at 37°C. Samples were 
separated by SDS-PAGE. The upper panels correspond to the Coomassie blue-stained gels, 
showing the presence of comparable amounts of PknH in each assay, the middle panels 
correspond to the corresponding autoradiograms, whereas the lower panels reflect densitometric 
analysis. In the case of EmbR2, each bar represent the mean of values from three independent 
experiments. 
 
Figure 5. PknH-dependent phosphorylation of EmbR is inhibited by EmbR2. Equal 
amounts of purified GST-PknH (0.3 µg) and EmbR (1 µg) were incubated with increasing 
concentrations (up to 3 µg) of EmbR2 with [γ-33P]ATP for 20 min at 37°C. Samples were 
separated by SDS-PAGE and the effect of EmbR2 on PknH and EmbR phosphorylation was 
visualized by autoradiography. The upper panels represent the corresponding autoradiograms, 
whereas the lower panels reflect densitometric analysis. In a control experiment, EmbR2 was 
replaced by GST.  
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Table 1 : Phosphopeptide binding of EmbR2. Intensity of Trp fluorescence emission at 330 
nm was evaluated as a function of concentration of three different PknH-derived 
phosphopeptides (DEKLpTQLGT containing the pThr170, TQLGpTAVGT containing the 
pThr174, and DSAGpTLVSS containing the pThr222) as well as the Rad53p-ligand  
(SLEVpTEADT). The Kd values are as indicated.  
 
 
 
 
 
Phosphopeptide sequence Kd (in µM)  
DEKLpTQLGT 18.3 ± 4.4  
TQLGpTAVGT 21.1 ± 4.1  
DSAGpTLVSS 11.9 ± 1.7  
SLEVpTEADT 17.1 ± 1.4  
PknH
Rad53p 
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EmbR_MtubH37Rv      1 MAGSATVEKRLDFGLLGPLQMTIDGTPVPSGTPKQRAVLAMLVINRNRPVGVDALITALW
EmbR2_MtubCDC1551   1 MAR.....NELRFGILGPLEISAGFRSLPLGTPKQRAVLATLIIHRNRPVGIDSLIDAAW
EmbR_MtubH37Rv      61 EEWPPSGARASIHSYVSNLRKLLGGAGIDPRVVLAAAPPGYRLSIPDNTCDLGRFVAEKT
EmbR2_MtubCDC1551   56 EQDRPEGSRATVYTYVSNLRRLVSTTGADSHSILASAPPGYRLAVADNQYDVARFISQRS
EmbR_MtubH37Rv     121 AGVHAAAAGRFEQASRHLSAALREWRGPVLDDLRDFQFVEPFATALVEDKVLAHTAKAEA
EmbR2_MtubCDC1551  116 AGLRAAAAGSFEQASDHLSAALAEWRGPVLDDLREFSFVTRLANSLVEDKIIAHTALAEA
EmbR_MtubH37Rv     181 EIACGRASAVIAELEALTFEHPYREPLWTQLITAYYLSDRQSDALGAYRRVKTTLADDLG
EmbR2_MtubCDC1551  176 EIACGRADSVISELEELILEHPYHEALWRQLIAAYYVSERQSDALDAYRRLKTSLAEDLG
EmbR_MtubH37Rv     241 IDPGPTLRALNERILRQQPLDAKKSAKTTAAGTVTVLDQRTMASGQQAVAYLHDIASGRG
EmbR2_MtubCDC1551  236 VDPGPKVRTLYEQVLRQQALDTRVVVQAAAGDIIRALEHSPGMTDRSPRAAIRDAAGHR.
EmbR_MtubH37Rv     301 YPLQAAATRIGRLHDNDIVLDSANVSRHHAVIVDTGTNYVINDLRSSNGVHVQHERIRSA
EmbR2_MtubCDC1551  295 SPLGRLPLRIGRSKSNDMVLPDGKVSPYHAVIVNTGESFMITDLRSVNGVYVRGRRIATT
EmbR_MtubH37Rv     361 VTLNDGDHIRICDHEFTFQISAGTHGGT
EmbR2_MtubCDC1551  355 ATLNDGDHIRIGDHELTFEVIPHESGR.
moaDE      moaC-3                      moaA-3     MT3427.1        MT3428 (embR2)      MT3429                        MT3430 
 MT3426                                                                                                                         MT3431 
1000 bp 
M. tuberculosis  CDC1551 
      
     3705263                                            3707313                   3708458                     3709688 
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O6-cyclohexylmethylguanine                   EmbR2 
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A
B
N
N
N
H
N
O
H2N
O6-cyclohexylmethylguanine
O6-cyclohexylmethylguanine
PknA     PknB    PknD    PknE   
-     +      -   +     -     +     -     +
  PknF    PknH     PknK     PknL
-     +      -   +     -     +     -     +
PknH
EmbR2
0      0.5     1        2      3 µg
PknH
EmbR2
0     5    15   25    50   100µM 
PknH
PknH
100%
81%
52%
26%
16%
0
20
40
60
80
100
 R
ad
io
ac
ti
vi
ty
 In
te
n
si
ty
 (
%
) 
100%
53%
31%
15%
5% 4%
0
20
40
60
80
100
 R
ad
io
ac
ti
vi
ty
 In
te
n
si
ty
 (
%
) 
S
ag
e 2
(a)
 PO
ST
-PR
INT
Biochemical Journal Immediate Publication. Published on 14 Nov 2007 as manuscript BJ20071384
TH
IS
 IS
 N
O
T 
TH
E 
FI
NA
L 
VE
RS
IO
N 
- s
ee
 d
oi
:1
0.
10
42
/B
J2
00
71
38
4
Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
© 2007 The Authors Journal compilation © 2007 Biochemical Society
Figure 5 
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